XML 23 R6.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss).
Non-Controlling Interest
Total
Balance at beginning of period at Dec. 31, 2019 $ 342 $ 58,017 $ (64,512)   $ 1,791 $ (4,362)
Balance at beginning of period (in shares) at Dec. 31, 2019 34,202,000          
Change in accounting principle     6,626     6,626
Net income (loss)     (129,171)   306 (128,865)
Other comprehensive income (loss)       $ 3,820   3,820
Equity-based compensation   1,553       1,553
Accumulating preferred dividends     (18,513)     (18,513)
Balance at end of period at Dec. 31, 2020 $ 342 59,570 (205,570) 3,820 2,097 (139,741)
Balance at end of period (in shares) at Dec. 31, 2020 34,202,000          
Net income (loss)     (21,947)   639 (21,308)
Other comprehensive income (loss)       8,198   8,198
Equity-based compensation $ 3 1,220       1,223
Equity-based compensation (in shares) 321,000          
Net share settlement of equity awards   (162)       (162)
Accumulating preferred dividends     (24,208)     (24,208)
Balance at end of period at Dec. 31, 2021 $ 345 60,628 (251,725) 12,018 2,736 (175,998) [1]
Balance at end of period (in shares) at Dec. 31, 2021 34,523,000          
Net income (loss)     (55,185)   (276) (55,461)
Issuance of common shares upon closing of de-SPAC merger transaction, net of issuance costs, net of $2,469 of taxes (see Note 4) $ 129 1,738       1,867
Issuance of common shares upon closing of de-SPAC merger transaction, net of issuance costs, net of $2,469 of taxes (see Note 4) (Units) 12,868,000          
Issuance of common shares related to PIPE financing $ 206 205,694       205,900
Issuance of common shares related to PIPE financing (in units) 20,590,000          
Issuance of common shares related to conversion of debt to equity (see Note 12) $ 25 24,975       25,000
Issuance of common shares related to conversion of debt to equity (see Note 12) (in units) 2,500,000          
Issuance of common shares related to conversion of Common Equivalent Preferred Units (see Note 4) $ 22 23,731       23,753
Issuance of common shares related to conversion of Common Equivalent Preferred Units (see Note 4) (in units) 2,220,000          
Issuance of common shares related to Public Warrant exercise $ 1 1,272       $ 1,273
Issuance of common shares related to Public Warrant exercise (in shares) 94,000         0
Issuance of common shares related to stock options exercised   375       $ 375
Issuance of common shares related to stock options exercised (in shares) 39,000         39,344
Issuance of common shares related to Kohana acquisition (see Note 6) $ 19 23,416       $ 23,435
Issuance of common shares related to Kohana acquisition (in shares) (see Note 6) 1,853,000          
Common Equivalent Preferred Unit dividends ($0.02 per unit)     (4,380)     (4,380)
Loss on extinguishment of Common Equivalent Preferred units     (2,870)     (2,870)
Accretion of convertible preferred stock   (1,316)       (1,316)
Other comprehensive income (loss)       (18,121)   (18,121)
Equity-based compensation $ 3 2,628       2,631
Equity-based compensation (in shares) 333,000          
Net share settlement of equity awards   (477)       (477)
Accumulating preferred dividends     (13,882)     (13,882)
Balance at end of period at Dec. 31, 2022 $ 750 $ 342,664 $ (328,042) $ (6,103) $ 2,460 $ 11,729 [1]
Balance at end of period (in shares) at Dec. 31, 2022 75,020,000          
[1] (1) Retroactively adjusted for de-SPAC merger transaction as described in Note 4.